Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy.
暂无分享,去创建一个
M. Baccarani | H. Kantarjian | B. Druker | J. Lipton | D. Niederwieser | R. Stone | R. Silver | A. Countouriotis | T. Facon | A. Hochhaus | N. Shah | S. Goldberg | F. Cervantes | J. Apperley | R. Ezzeddine | M. C. Muller | T. Hughes | Martin C Muller